$ Value
$0
Shares
609
Price
$0
Filed
Oct 3
Insider
Name
Renaudin George II
Title
President, Insurance
CIK
0001964078
Roles
Transaction Details
Transaction Date
2025-10-01
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
16,311
Footnotes
Shares held for the benefit of reporting person as of September 30, 2025 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c). | Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. | Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. | Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). | Restricted stock units granted to reporting person on 10/1/2022, 100% of the award is vesting on 10/1/2025. | Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25. | Includes 11,165 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. | Phantom Stock Units held for the benefit of reporting person as of September 30, 2025 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price. | Shares disposed of represent payment for tax liability on restricted stock vesting on 10/1/25. No value was received in return.
Filing Info
Renaudin George II's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-31 | HUM | J | $4K |
| 2026-02-24 | HUM | M | $0 |
| 2026-02-24 | HUM | F | $74K |
| 2025-12-15 | HUM | M | $0 |
| 2025-12-15 | HUM | F | $224K |
| 2025-12-15 | HUM | M | $0 |
| 2025-12-15 | HUM | F | $38K |
| 2025-12-15 | HUM | M | $0 |
| 2025-10-01 | HUM | M | $0 |
| 2025-10-01 | HUM | F | $61K |
Other Insiders at HUM (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Shetty Sanjay K
President, CenterWell
|
$150K | — | 2026-04-01 |
| HILZINGER KURT J | — | — | 2026-03-31 |
|
Mellet Celeste
Chief Financial Officer
|
— | — | 2026-02-13 |
|
Ventura Joseph C
Chief Legal Officer
|
— | — | 2026-02-24 |
|
Felter John-Paul W.
SVP, Chief Accting Off & Cont.
|
— | — | 2026-02-24 |
|
Renaudin George II
President, Insurance
|
— | — | 2026-03-31 |
|
Dintenfass David
President, Enterprise Growth
|
— | — | 2026-02-21 |
|
Mehta Japan
Chief Information Officer
|
— | — | 2026-02-13 |
|
Martin Aaron
President, Medicare Advantage
|
— | — | 2026-02-12 |